Johnson & Johnson (JNJ) Receivables (2009 - 2026)

Johnson & Johnson has disclosed Receivables across 18 years of filings, most recently posting $19.0 billion for Q2 2026.

• In Q2 2026, Receivables rose 6.72% year-over-year to $19.0 billion; the TTM figure through Jun 2026 stood at $19.0 billion (up 6.72% YoY), while the FY2025 annual figure was $17.2 billion, up 15.74% from the prior year.
• Receivables came in at $19.0 billion for Q2 2026 at Johnson & Johnson, up from $17.7 billion in the prior quarter.
• In the past five years, Receivables ranged from a high of $19.0 billion in Q2 2026 to a low of $14.0 billion in Q1 2023.
• Average Receivables over 5 years is $16.2 billion, with a median of $16.0 billion recorded in 2025.
• Year-over-year, Receivables decreased 8.59% in 2024 and climbed 15.74% in 2025.
• Over 5 years, Receivables stood at $15.9 billion in 2022, then decreased by 6.4% to $14.9 billion in 2023, then fell by 0.21% to $14.8 billion in 2024, then grew by 15.74% to $17.2 billion in 2025, then rose by 10.87% to $19.0 billion in 2026.
• Per Business Quant data, the three most recent Receivables figures were $19.0 billion in Q2 2026, $17.7 billion in Q1 2026, and $17.2 billion in Q4 2025.